Clarity Pharmaceuticals has reported its annual loss to be A$24.6 million.
This is slightly higher than the previous year’s loss of A$23.8 million.
Clarity Pharmaceuticals (ASX:CU6) offers pharmaceutical services specializing in nuclear medicine and molecular imaging products.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
